Omepra

/ Rafa

See prescribing information for full details.

Acute duodenal/gastric ulcer, Helicobacter pylori associated peptic ulcer disease in combination with antibiotics. Reflux esophagitis: Long-term management treatment, maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. Treatment of severe reflux esophagitis in children from one year of age and older. Maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. Zollinger-Ellison Syndrome. Treatment and prevention of NSAID-associated duodenal and gastric ulcer or erosions in high risk patients.

Known hypersensitivity. Concomitant treatment with alazanavir.

Pregnancy and lactation, pediatrics, hepatic disease. Malignancy should be excluded before commencement of treatment if gastric ulcer is suspected.
See literature.

Headache, diarrhea, constipation, abdominal pain, nausea/vomiting, flatulence, and less common: Rash, urticaria, pruritus, malaise, dizziness, paresthesia, increased liver enzymes, somnolence, insomnia, and vertigo.